Suominen Oyj manufactures nonwovens as roll goods for wipes and hygiene products and medical applications. Its products include wipes for personal hygiene, baby care, household and workplace, sanitary pads, diapers, and surgical drapes swabs. The firm generates the majority of its sales from the United States.
2001
673
LTM Revenue $484M
LTM EBITDA $21.7M
$192M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Suominen has a last 12-month revenue of $484M and a last 12-month EBITDA of $21.7M.
In the most recent fiscal year, Suominen achieved revenue of $470M and an EBITDA of $10.0M.
Suominen expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Suominen valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $514M | $470M | $481M | $484M | XXX |
Gross Profit | $53.0M | $19.4M | $23.7M | XXX | XXX |
Gross Margin | 10% | 4% | 5% | XXX | XXX |
EBITDA | $17.0M | $10.0M | $19.9M | $21.7M | XXX |
EBITDA Margin | 3% | 2% | 4% | 4% | XXX |
Net Profit | $21.6M | -$14.4M | -$13.3M | XXX | XXX |
Net Margin | 4% | -3% | -3% | XXX | XXX |
Net Debt | $33.2M | $41.5M | $32.0M | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Suominen's stock price is EUR 2 (or $2).
Suominen has current market cap of EUR 122M (or $127M), and EV of EUR 185M (or $192M).
See Suominen trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$192M | $127M | XXX | XXX | XXX | XXX | $-0.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Suominen has market cap of $127M and EV of $192M.
Suominen's trades at 0.4x LTM EV/Revenue multiple, and 8.8x LTM EBITDA.
Analysts estimate Suominen's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Suominen and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $192M | XXX | XXX | XXX |
EV/Revenue | 0.4x | XXX | XXX | XXX |
EV/EBITDA | 9.7x | XXX | XXX | XXX |
P/E | -23.6x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -31.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSuominen's NTM/LTM revenue growth is 4%
Suominen's revenue per employee for the last fiscal year averaged $0.7M, while opex per employee averaged $44K for the same period.
Over next 12 months, Suominen's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Suominen's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Suominen and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 2% | XXX | XXX | XXX | XXX |
EBITDA Margin | 4% | XXX | XXX | XXX | XXX |
EBITDA Growth | 99% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 8% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.7M | XXX | XXX | XXX | XXX |
Opex per Employee | $44K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
Opex to Revenue | 6% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Suominen acquired XXX companies to date.
Last acquisition by Suominen was XXXXXXXX, XXXXX XXXXX XXXXXX . Suominen acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Suominen founded? | Suominen was founded in 2001. |
Where is Suominen headquartered? | Suominen is headquartered in Finland. |
How many employees does Suominen have? | As of today, Suominen has 673 employees. |
Who is the CEO of Suominen? | Suominen's CEO is Mr. Tommi Bjornman. |
Is Suominen publicy listed? | Yes, Suominen is a public company listed on HEL. |
What is the stock symbol of Suominen? | Suominen trades under SUY1V ticker. |
When did Suominen go public? | Suominen went public in 2001. |
Who are competitors of Suominen? | Similar companies to Suominen include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
What is the current market cap of Suominen? | Suominen's current market cap is $127M |
What is the current revenue of Suominen? | Suominen's last 12-month revenue is $484M. |
What is the current EBITDA of Suominen? | Suominen's last 12-month EBITDA is $21.7M. |
What is the current EV/Revenue multiple of Suominen? | Current revenue multiple of Suominen is 0.4x. |
What is the current EV/EBITDA multiple of Suominen? | Current EBITDA multiple of Suominen is 8.8x. |
What is the current revenue growth of Suominen? | Suominen revenue growth between 2023 and 2024 was 2%. |
Is Suominen profitable? | Yes, Suominen is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.